Physician profile
Crystal Cole
NPI 1902053408
$243.00
in general payments reported to CMS, 2019-2025
8 companies · $29.61 in 2025
The $29.61 reported for 2025 was less than what a typical Adolescent Medicine (Pediatrics) provider received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.52 · 2020: $57.40 · 2022: $38.02 · 2023: $37.82 · 2024: $17.63 · 2025: $29.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $85.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $85.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $80.84 | 2019-2022 | |
| Mylan Pharmaceuticals INC. | $36.96 | 2019-2022 | |
| Glaxosmithkline, LLC. | $33.62 | 2020-2025 | Menveo, Flulaval Quadrivalent, Bexsero |
| Exeltis, USA INC. | $20.72 | 2023 | Slynd |
| Therapeuticsmd, INC. | $20.00 | 2020 | |
| Merck Sharp & Dohme LLC | $17.63 | 2024 | Gardasil, Gardasil 9 |
| Organon LLC | $17.10 | 2023 | Nexplanon |
| Supernus Pharmaceuticals, INC. | $16.13 | 2025 | Qelbree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Crystal Cole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.